Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Thimme

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Deutsche Medizinische Wochenschrift (1946)|July 17, 2004
[Suppressor T-cells: immunologic regulator cells and clinical perspectives]C Neumann-Haefelin, H C Spangenberg, R Thimme, et al.
Journal of Virology|March 27, 2001
Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51R Thimme, K M Chang, J Pemberton, et al.
Alimentary Pharmacology & Therapeutics|September 28, 2016
Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS)D Bettinger, M Schultheiss, T Boettler, et al.
Deutsche Medizinische Wochenschrift (1946)|February 13, 2004
[Diagnosis and treatment of hepatocellular carcinoma]H C Spangenberg, I Zuber-Jerger, L Mohr, et al.
Zentralblatt Fur Chirurgie|December 12, 2003
[Systemic treatment for hepatocellular carcinoma]H C Spangenberg, I Zuber-Jerger, R Thimme, et al.
Digestion|September 4, 1999
Ampullary hamartoma: A rare cause of biliary obstructionH P Allgaier, H Schwacha, M Kleinschmidt, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2018
Treatment with proton pump inhibitors is associated with increased mortality in patients with pyogenic liver abscessD Bettinger, D Martin, S Rieg, et al.
Alimentary Pharmacology & Therapeutics|October 21, 2014
Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinomaD Bettinger, E Knüppel, W Euringer, et al.
The Journal of Experimental Medicine|November 21, 2001
Determinants of viral clearance and persistence during acute hepatitis C virus infectionR Thimme, D Oldach, K M Chang, et al.
Alimentary Pharmacology & Therapeutics|December 17, 2014
Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma - authors' replyD Bettinger, E Knüppel, W Euringer, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Deutsche Medizinische Wochenschrift (1946)|July 17, 2004
[Suppressor T-cells: immunologic regulator cells and clinical perspectives]C Neumann-Haefelin, H C Spangenberg, R Thimme, et al.
Journal of Virology|March 27, 2001
Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51R Thimme, K M Chang, J Pemberton, et al.
Alimentary Pharmacology & Therapeutics|September 28, 2016
Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS)D Bettinger, M Schultheiss, T Boettler, et al.
Deutsche Medizinische Wochenschrift (1946)|February 13, 2004
[Diagnosis and treatment of hepatocellular carcinoma]H C Spangenberg, I Zuber-Jerger, L Mohr, et al.
Zentralblatt Fur Chirurgie|December 12, 2003
[Systemic treatment for hepatocellular carcinoma]H C Spangenberg, I Zuber-Jerger, R Thimme, et al.
Digestion|September 4, 1999
Ampullary hamartoma: A rare cause of biliary obstructionH P Allgaier, H Schwacha, M Kleinschmidt, et al.
Alimentary Pharmacology & Therapeutics|January 13, 2018
Treatment with proton pump inhibitors is associated with increased mortality in patients with pyogenic liver abscessD Bettinger, D Martin, S Rieg, et al.
Alimentary Pharmacology & Therapeutics|October 21, 2014
Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinomaD Bettinger, E Knüppel, W Euringer, et al.
The Journal of Experimental Medicine|November 21, 2001
Determinants of viral clearance and persistence during acute hepatitis C virus infectionR Thimme, D Oldach, K M Chang, et al.
Alimentary Pharmacology & Therapeutics|December 17, 2014
Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma - authors' replyD Bettinger, E Knüppel, W Euringer, et al.
Pageof 8